Hologen Limited specialises in building AI models from real-world data for use in healthcare. Hologen’s technology can be applied to Phase 2 and 3 clinical trials to enable accurate quantification of therapeutic effects, and illuminates disease mechanisms opaque to conventional models, revealing new therapeutic and commercial opportunities.